TCI Wealth Advisors’s Privia Health PRVA Stock Holding History

TCI Wealth Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-59	Closed	-$1.34K	–	2611
2022 Q4	$1.34K	Buy	+59	New	+$1.64K	﹤0.01%	2062

Other funds holding PRVA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCI Wealth Advisors's PRVA Position: Q1 2023 in Review

TCI Wealth Advisors sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 59 shares — an estimated $1.34K sold.

TCI Wealth Advisors first reported a position in PRVA in Q4 2022 and held it in 1 quarter. The position peaked at $1.34K in Q4 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

TCI Wealth Advisors reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
TCI Wealth Advisors sold 59 Privia Health shares in Q1 2023, an estimated $1.34K.
TCI Wealth Advisors first reported a position in Privia Health in Q4 2022 and held it in 1 quarter.
TCI Wealth Advisors's Privia Health position peaked at $1.34K in Q4 2022.
191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.